tiprankstipranks
Trending News
More News >
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
US Market

Aligos Therapeutics (ALGS) Income Statement

Compare
253 Followers

Aligos Therapeutics Income Statement

Last quarter (Q3 2025), Aligos Therapeutics's total revenue was $741.00K, a decrease of -41.61% from the same quarter last year. In Q3, Aligos Therapeutics's net income was $-31.54M. See Aligos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.94M$ 15.53M$ 13.91M$ 4.36M$ 0.00
Gross Profit
$ 3.94M$ 15.53M$ 13.91M$ 4.36M$ -3.33M
Operating Expenses
$ 93.10M$ 103.66M$ 111.49M$ 132.68M$ 94.51M
Depreciation and Amortization
$ 2.62M$ 3.07M$ 3.67M$ 3.78M$ 3.33M
EBITDA
$ -86.53M$ -85.06M$ -93.91M$ -124.54M$ -105.06M
Operating Income
$ -89.15M$ -88.13M$ -97.58M$ -128.32M$ -97.83M
Other Income/Expenses
$ -41.73M$ 1.24M$ 1.64M$ 132.00K$ -10.55M
Pretax Income
$ -130.88M$ -86.88M$ -95.94M$ -128.19M$ -108.38M
Net Income
$ -131.21M$ -87.68M$ -96.05M$ -128.33M$ -108.54M
Per Share Metrics
Basic EPS
$ -20.94$ -3.52$ -2.25$ -3.22$ -3.18
Diluted EPS
$ -20.94$ -3.52$ -2.25$ -3.22$ -3.18
Weighted Average Shares Outstanding
6.26M 24.87M 42.70M 39.86M 34.18M
Weighted Average Shares Outstanding (Diluted)
6.26M 24.87M 42.70M 39.86M 34.18M
Currency in USD

Aligos Therapeutics Earnings and Revenue History